MetabolicResearch peptide

Cagrilintide

Cagrilintide is a long-acting amylin analog being studied as a standalone and in combination with semaglutide (CagriSema). Research focuses on satiety signaling and its role in metabolic studies.

Also known as: AM833, NN9838

Technical information

Molecular weight

3751.4 g/mol

Half-life

~7 days (subcutaneous)

Sequence

Modified 37-amino acid amylin analog

Common research doses

0.3-4.5 mg weekly (research protocols)

Research areas

Amylin signalingSatiety researchMetabolic studiesCombination therapy

For research purposes only. PepAssure provides vendor information as a verification service and does not endorse or recommend any specific use. Consult qualified research protocols and institutional review boards.